483 Patheon Pharmaceuticals May 2013

483 Patheon Pharmaceuticals May 2013

Cynthia Cain FDA, Michael Sheehan FDA$119.00 - Available Now

FDA investigators audited the Patheon Pharmaceuticals - Cincinnati, OH, United States facility and issued 1 inspectional observation (via FDA 483) on 13 May 2013.

Product details

  • Category: Human Drugs
  • Number of Observations: 1
  • Inspection end: 13 May 2013
  • Location: Cincinnati, United States
  • FEI: 1510437
Add To Cart